SABS
SAB Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
SABS fundamentals
SAB Biotherapeutics (SABS) released its earnings on Aug 7, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -1.09 (YoY -37.97%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-1.09
-37.97%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
SAB Biotherapeutics (SABS) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
SAB Biotherapeutics (SABS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
SAB Biotherapeutics (SABS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
SAB Biotherapeutics (SABS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does SAB Biotherapeutics (SABS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track SAB Biotherapeutics (SABS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is SAB Biotherapeutics's latest dividend and current dividend yield?What were the key takeaways from SAB Biotherapeutics’s earnings call?Did SAB Biotherapeutics beat or miss consensus estimates last quarter?What factors drove the changes in SAB Biotherapeutics's revenue and profit?What does SAB Biotherapeutics do and what are its main business segments?What is the revenue and EPS growth rate for SAB Biotherapeutics year over year?What guidance did SAB Biotherapeutics's management provide for the next earnings period?What were the key takeaways from SAB Biotherapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
